Molecules in focus
Intracellular labile iron

https://doi.org/10.1016/j.biocel.2007.03.010Get rights and content

Abstract

Cells maintain organellar pools of “labile iron” (LI), despite its propensity for catalyzing the formation of reactive oxygen species. These pools are identifiable by iron-chelating probes and accessible to pharmacological agents. Cytosolic LI has been assumed to have a dual function: providing a rapidly adjustable source of iron for immediate metabolic utilization, and for sensing by iron-regulatory proteins (IRPs) that regulate iron uptake and compartmentalization via transferrin receptors and ferritin. However, it now appears that IRPs may respond both to fluctuations in LI per se and to secondary signals associated with redox-active species. Recent information also indicates that iron can be delivered to mitochondria via pathways that circumvent cytosolic LI, suggesting possible alternative mechanisms of cell iron mobilization and trafficking. We discuss the changing views of intracellular LI pools in relation to iron homeostasis and cellular distribution in physiological and pathological states.

Introduction

The existence of a cellular pool of metabolically available, labile iron (LI), has remained controversial. Firstly, its inherently transient nature, susceptibility to exchange between chemical ligands and to environment-sensitive redox conversions, have made it difficult to chemically quantify or even characterize. Secondly, the actual concept of cellular pools of LI might be considered counterintuitive, as it would entail the heavy cost of coping with continual iron-catalyzed generation of toxic reactive oxygen species (ROS). The development of iron-sensitive fluorescent probes has provided much evidence in favor of intracellular LI pools. Cytosolic LI is still portrayed as a key player in the cell iron-sensing machinery and hub of iron homeostasis (reviewed in Kakhlon & Cabantchik, 2002; Kruszewski, 2003). Yet, there remains considerable uncertainty about the mechanisms by which it affects iron-handling proteins and is in turn influenced by them. The notion of diffusible LI that is randomly bound to cellular ligands of variable affinities does not exclude the possibilities of escorted iron delivery to organelles and ensuing compartmentalization. The purpose of this review is to critically examine these evolving concepts and open questions, and point out new directions for investigating cellular LI.

Section snippets

Probing intracellular labile iron

Probes for LI are comprised of a fluorescent reporter group coupled to a high-affinity iron(II or III) chelator. The fluorophore responds to metal binding by undergoing a change in fluorescence, ideally in a stoichiometric manner. The most commonly used fluorophores include fluorescein and rhodamine derivatives attached to either desferrioxamine, phenanthroline, bipyridyl, ethylene-diamine tetraacetate, ferrichromes (reviewed in Esposito, Epsztejn, Breuer, & Cabantchik, 2002) or pyridinones (

Cellular LI as a chelator-accessible source of reactive oxygen species

The generation of reactive oxygen species (ROS) via the Fenton reaction is virtually unavoidable in cellular systems that contain both redox-active LI and generate reactive oxygen intermediates such as superoxide and/or H2O2. Redox activity requires the cycling of iron between the di- and tri-valent states, which may be expected within cells due to the reducing intracellular environment and activity of ferric reductases. It has been shown that ≥80% of the ∼0.4 μM LI in erythroleukemia K562 cells

Future directions

A major future challenge will be the analysis of LI in crucial compartments using organelle-specific probes. For example, the growing list of neurological diseases recognized as mitochondria-related includes several conditions with suspected disruptions in mitochondrial LI levels.

The model of cellular iron distribution, in which various cellular components receive iron directly from a cytosolic LI pool is likely to undergo revision. Its relevance will depend on the identification of the forms

Acknowledgements

We acknowledge the support of Euroiron1, LSHM-CT-2006-037296, Apotex Inc., Ont. Canada, Association Francaise de Myotonie and the Israeli Science Foundation.

Cited by (0)

View full text